Biotech

All Articles

Praxis epilepsy drug decreases seizures in stage 2 trial

.Practice Precision Medicines has actually racked up an additional midphase succeed in epilepsy this...

Three execs surrender as Dyne articles blended information for DMD candidate

.After running away a medical hold a number of years back, Dyne Rehab has actually uncovered brand-n...

Arrowhead fires off stage 3 data in rare metabolic health condition before market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its hand in front of a possible showdown along wit...

Pfizer, Valneva show lyme condition try successful for second enhancer

.Pfizer as well as Valneva might possess concerning two more years to wait prior to they help make t...

Fierce Biotech Managing Editor Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a conversation with Ayla Ellison, Fierce Biotech Editor-in-Chief as well as Miche...

New information show how Bayer's asundexian stopped working to prevent strokes

.Bayer suspended the phase 3 test for its own factor XIa prevention asundexian behind time last year...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its own several sclerosis (MS) med tolebrutinib to the FDA, manage...

Galapagos' stock up as fund presents intent to shape its evolution

.Galapagos is happening under extra stress from clients. Having actually built a 9.9% concern in Gal...

Cell- centered Sana scoops first CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Allist settles Jacobio $21M, landing role in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually gotten on its own a starring job in China's KRAS marke...